Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Serstech ABOSTO:SERT +3.41%35 Equity-to-Asset is 0.62 as of Jun. 2026, which is 24% below its 10-year median of 0.82. GuruFocus rates OSTO:SERT with a GF Score™ of 35/100 and a GF Value™ of kr0.40 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,616 Chemicals companies, Serstech AB ranks better than 54.95% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Serstech AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr36.02 Mil. Serstech AB's Total Assets for the quarter that ended in Jun. 2026 was kr58.33 Mil.
Therefore, Serstech AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.62.
The historical rank and industry rank for Serstech AB's Equity-to-Asset or its related term are showing as below:
OSTO:SERT'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.51 Med: 0.82 Max: 0.9
Current: 0.62
During the past 13 years, the highest Equity to Asset Ratio of Serstech AB was 0.90. The lowest was 0.51. And the median was 0.82.
OSTO:SERT's Equity-to-Asset is ranked better than 54.95% of 1616
companies
in the Chemicals industry
Industry Median: 0.6
vs OSTO:SERT: 0.62
Serstech AB (OSTO:SERT) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Serstech AB Equity-to-Asset Related Terms
Serstech AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Serstech AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Serstech AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Serstech AB Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Serstech AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Serstech AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Serstech AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Serstech AB (OSTO:SERT) has a Equity-to-Asset of 0.62 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Serstech AB and its competitors. This is 24% below median its historical median of 0.82. Over the past decade, Serstech AB's Equity-to-Asset has ranged from 0.51 to 0.90. According to the industry distribution chart, Serstech AB ranks #728 out of 1616 companies in the Chemicals industry, placing it in the top 45%.
Is Serstech AB's Equity-to-Asset too high?
Serstech AB's current Equity-to-Asset of 0.62 is 24% below median its 10-year median of 0.82. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 0.90. The Chemicals industry median Equity-to-Asset is 0.60. Serstech AB's value of 0.62 is 3.3% above this industry median. Based on the distribution chart, Serstech AB ranks #728 out of 1616 companies in the Chemicals industry, which is above the industry midpoint. Overall, Serstech AB has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Serstech AB's Equity-to-Asset compare to DOW?
According to the Chemicals industry distribution chart, Serstech AB ranks #728 out of 1616 companies for Equity-to-Asset. This puts Serstech AB in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Serstech AB's value of 0.62 is 3.3% above this benchmark. Historically, Serstech AB's own Equity-to-Asset has ranged from 0.51 to 0.90 over the past decade. While the company's 10-year median is 0.82 vs. the industry median of 0.60, Serstech AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,616 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Serstech AB's current Equity-to-Asset of 0.62 is 3.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Serstech AB and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Serstech AB's current Equity-to-Asset is 0.62, which is 24% below median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Serstech AB stock overvalued right now?
Based on GuruFocus' analysis, Serstech AB (OSTO:SERT) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.40, compared to a current price of kr0.55 — trading 36.5% above its estimated fair value. The current Equity-to-Asset is 0.62, which is 24% below median its 10-year median of 0.82 and 3.3% above the Chemicals industry median of 0.60. Serstech AB's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Serstech AB (OSTO:SERT), the current Equity-to-Asset is 0.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Serstech AB (OSTO:SERT) Overvalued in 2026?
Based on GuruFocus' analysis, Serstech AB stock appears to be overvalued.
The current stock price of kr0.55 is trading 36.5% above its estimated GF Value™ of kr0.40.
GuruFocus considers Serstech AB to be Significantly Overvalued.
Key valuation signals for OSTO:SERT:
Equity-to-Asset: 0.62 (24% below median its 10-year median of 0.82)
GF Value™: kr0.40 vs. price of kr0.55 (36.5% above fair value)
Industry Position: 3.3% above the Chemicals median (#728 of 1616)
No single metric tells the full story. See the OSTO:SERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Serstech AB is engaged in chemical related products which help in the measurement and identification of chemicals. It offers Handheld Raman Spectrometer; Chemdash, Management and Reporting Software and Validated Data-Enriched and Complete Libraries. The company's solutions are used in the pharmaceutical production industry.
35GF Score
Get the complete analysis for OSTO:SERT
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SERT has been successfully added to your 
